VC life science investment wanes in Q3 (MassDevice)
Venture capitalists' investments in life science companies waned during the third quarter to its lowest point since the first quarter of 2009.
Venture capitalists invested $1.8 billion in 170 life sciences deals during the third quarter, down 18 percent compared with Q2, and marking the lowest number of deals since the first quarter of 2009.
Still, VC life science investment is still on track to top last year's numbers, according to theMoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Assn. Compared with Q3 201...
